Figure 3 CD133 expression in HCC, intrahepatic cholangiocarcinoma, and combined hepatocellular and cholangiocarcinoma (immunostaining).
In HCC, a few carcinoma cells expressed CD133, and those cells were CK19- and HepPar-1+ (arrows). In cholangiocarcinoma, CD133 was expressed diffusely in carcinoma cells, and CK19 was also positive. In combined carcinoma, CD133 was expressed mainly in carcinoma cells positive for CK19, whereas some carcinoma cells were CD133+/CK19-/HepPar-1+ (arrows). All images, × 400.
©2009 The WJG Press and Baishideng.